What was once a relatively small class of drugs has become one of the most significant drivers of pharmacy spend, transforming diabetes care and offering new treatment options to help address obesity
The pharmaceutical company Eli Lilly produces both Mounjaro and Zepbound
Obesity is generally considered a chronic condition, and many weight loss medications are intended to support long-term weight management
Based on the treatment policy estimand, Semaglutide significantly reduced body weight compared to the placebo after 104 weeks
Yes, MeAgain tracks various GLP-1 medications including Ozempic, Wegovy, Mounjaro, Zepbound, semaglutide, and tirzepatide, as well as oral GLP-1s and weekly injection routines
A lower price doesnt automatically mean poor care but it does mean you should know exactly what youre paying for